Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX): Stock in Review

Monitoring some price target data, we have noticed that shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) currently have an average target of $12.93. This number is the consensus target price averaging estimates provided by analysts polled by Zacks Research. Sell-side analysts have various methods at their disposal for estimating stock price targets. Many investors will closely monitor stock target prices, especially when Street analysts change their view on a specific target price. Some investors may follow these sell-side targets very closely and use the provided information to assist with their own stock research.

Investors are always striving to locate the next great stock to add to the portfolio. Finding that next winner may involve some dedicated research and perseverance. Sorting through the immense amount of information about public companies can be a chore. Many sharp investors will attack the equity markets from many various angles. This may encompass keeping close tabs on fundamental and technical data. This may also include monitoring analyst opinions and tracking institutional transactions.  

We can now shift the focus to some company earnings data. Based on projections provided by 20 individual Wall Street analysts polled by Zacks Research, Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) has a current quarter EPS consensus estimate of 0.16. For the prior reporting period, the company posted quarterly earnings per share of 0.2. As earnings season continues, investors will be closely tracking analyst estimates. Sell-side analysts often make updates before and after the company reports earnings numbers. Following analyst estimate updates leading up to the earnings release may offer some good insight into the direction that the estimates are trending. Investors will be watching to see which companies post the largest earnings surprises this quarter.

Taking a look at the current consensus broker rating for Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX), we note that the ABR is 2.32. This Zacks consensus rating follows a numerical scale where a number in the 1-2 range generally represents a Buy, a 3 would indicate a Hold and 4-5 signals a Sell rating. In terms of the number of bullish analysts that have the stock rated a Buy or Strong Buy, we can see that the number is currently 8.

Investors may be following some historical price data on shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX). Over the past 12 weeks, the stock has seen a change of -17.99%. If we go back to the beginning of the year, we can see that shares have changed -0.73%. Over the last 4 weeks, shares have seen a change of -8.42%. Over the last 5 trading sessions, the stock has moved -0.21%. Investors will be monitoring stock activity over the next few weeks to try and gauge which way the momentum is leaning. Checking on some possible support and resistance levels, we have noted that that the 52-week high is currently $14.93, and the 52-week low is currently $8.64. When shares are trading close to the 52-week high or 52-week low, investors might be paying added attention. Looking at some recent action, we note that the stock has been seen trading near the $9.57 mark.

Investors are constantly trying to make smart moves in the stock market. Taking stock of personal strengths and weaknesses can help the investor attack the market with heightened focus. Often times, individuals may fall into traps that could have been avoided. Coming up with a sound investment plan and setting realistic expectations may help the novice investor become better prepared and focused. Positive returns are attainable with the proper preparation and dedication. Investors working with a longer-term plan might be approaching the stock market from a completely different angle than a shorter-term trader. Investors who plan to be in the market for a long period of time may not be as concerned about the day to day fluctuations as short-term traders. 

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *

*